Morning Overview on MSN
Thermodynamic computer mimics AI image generation using a fraction of the energy
Stephen Whitelam, a researcher whose work spans thermodynamic theory and machine learning, has described a framework for ...
Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...
Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...
AZoLifeSciences on MSN
Proteomics approaches to overcome undruggable targets in disease
This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...
Haoyu Cheng, Ph.D., assistant professor of biomedical informatics and data science at Yale School of Medicine, has developed a new algorithm capable of building complete human genomes using standard ...
4don MSN
Big data and human height: Scientists develop algorithm to boost biobank data retrieval and analysis
Extracting and analyzing relevant medical information from large-scale databases such as biobanks poses considerable challenges. To exploit such "big data," attempts have focused on large sampling ...
News-Medical.Net on MSN
Harnessing AI to optimize the development of new protein manufacturing processes
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...
AI can help protein engineers optimize the transcription enzymes used to make mRNA-based vaccines and therapeutics, say the authors of a new study.
AlphaGenome can analyse up to 1m letters of DNA code at once and could pave way for new treatments Researchers at Google DeepMind have unveiled their latest artificial intelligence tool and claimed it ...
Department of Chemistry and Biochemistry, University of South Carolina, Columbia, United States ...
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results